Approval of Affordable HIV-Prevention Shot Lenacapavir Raises Hopes, Faces Supply Challenges in Low-Income Countries

The approval of a cheaper version of the HIV-prevention shot lenacapavir offers significant hope for combating HIV in low-income countries. However, current shortages of the drug are hindering access for those who need it most, underscoring challenges in global health equity and distribution.